XML 85 R72.htm IDEA: XBRL DOCUMENT v3.23.2
Investments in and Advances to Joint Ventures - Summary of Financial Information for Consolidated Joint Ventures (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Schedule Of Equity Method Investments [Line Items]          
Current assets $ 1,980,208   $ 1,980,208   $ 1,719,783
Total assets 4,507,507   4,507,507   4,198,142
Current liabilities 1,294,901   1,294,901   1,108,119
Total liabilities 2,316,741   2,316,741   2,102,207
Total joint venture equity 2,119,431   2,119,431   2,043,570
Revenue 1,356,486 $ 1,008,721 2,529,952 $ 1,957,790  
Costs 1,068,220 781,772 1,985,408 1,515,672  
Net income attributable to Parsons Corporation 43,241 18,295 68,794 38,962  
Net income attributable to noncontrolling interests 11,530 4,485 21,253 7,661  
Consolidated Joint Ventures          
Schedule Of Equity Method Investments [Line Items]          
Current assets 374,942   374,942   289,837
Noncurrent assets 10,401   10,401   9,961
Total assets 385,343   385,343   299,798
Current liabilities 242,530   242,530   194,701
Noncurrent liabilities 3,399   3,399   3,763
Total liabilities 245,929   245,929   198,464
Total joint venture equity 139,414   139,414   $ 101,334
Revenue 167,253 108,089 328,737 203,623  
Costs 143,808 98,761 285,406 187,603  
Net income attributable to Parsons Corporation 23,445 9,328 43,331 16,020  
Net income attributable to noncontrolling interests $ (11,530) $ 4,485 $ 21,253 $ 7,661